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Although several genomewide scans have identiﬁed quantitative-trait loci inﬂuencing several obesity-related traits
in humans, genes inﬂuencing normal variation in obesity phenotypes have not yet been identiﬁed. We therefore
performed a genome scan of body mass index (BMI) on Mexican Americans, a population prone to obesity and
diabetes, using a variance-components linkage analysis to identify loci that inﬂuence BMI. We used phenotypic
data from 430 individuals (26% diabetics, 59% females, mean age  SD p 43  17 years, mean BMI  SD p
30.0  6.7, mean leptin (ng/ml)  SD p 22.1  17.1) distributed across 27 low-income Mexican American
pedigrees who participated in the San Antonio Family Diabetes Study (SAFDS) for whom a 10–15-cM map is
available. In this genomewide search, after accounting for the covariate effects of age, sex, diabetes, and leptin, we
identiﬁed a genetic region exhibiting the most highly signiﬁcant evidence for linkage (LOD 4.5) with BMI on
chromosome 4p (4p15.1) at 42 cM, near marker D4S2912. This linkage result has been conﬁrmed in an independent
linkage study of severe obesity in Utah pedigrees. Two strong positional candidates, the human peroxisome pro-
liferator-activated receptor gamma coactivator 1 (PPARGC1) and cholecystokinin A receptor (CCKAR) with major
roles in the development of obesity, are located in this region. In conclusion, we identiﬁed a major genetic locus
inﬂuencing BMI on chromosome 4p in Mexican Americans.
Introduction
Obesity is a complex phenotype resulting from the in-
teraction of both genetic and environmental factors.
Obesity is a risk factor for diseases such as type 2 dia-
betes (T2D), hypertension, and coronary heart disease
in all populations, particularly in minority populations
in the United States, such as Mexican Americans. Epi-
demiological studies have indicated that Mexican Amer-
icans are prone to complex diseases such as obesity, T2D,
dyslipidemia, gallbladder disease, and other metabolic
complications (Diehl and Stern 1989; Mitchell et al.
1990; Stern et al. 1990). The Mexican American pop-
ulation is also characterized by increased adiposity and
a more centralized distribution of body fat (Joos et al.
1984; Haffner et al. 1986), and it has an increased prev-
alence of T2D, compared with that among non-Hispanic
whites (Stern and Haffner 1990; Haffner et al. 1991).
Several studies have documented that genetic factors
are involved in the development of obesity, and ∼30%–
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40% of normal variation is attributable to genetic fac-
tors (Bouchard 1997; Barsh et al. 2000; Comuzzie et
al. 2001). Epidemiological studies involving twins,
adoptees, and families showed that heritability of BMI
or body fat varies from ∼25% in adoption studies to a
high of 70% in twin studies, whereas estimates are
∼40% in family studies (Bouchard 1997; Rice et al.
1997; Borecki et al. 1998; Comuzzie and Allison 1998;
Hager et al. 1998). Thus, genetic factors play a signif-
icant role in establishing an individual’s predisposition
to developing obesity, whereas environmental and psy-
chological factors contribute signiﬁcantly to the ex-
pression of the obesity phenotype as well (Comuzzie
and Allison 1998; Barsh et al. 2000; Kaplan 2000; Co-
muzzie et al. 2001).
Given the complexity of the obesity phenotype, it has
been reported that several important obesity genes may
be involved in the regulation of human adipose tissue
function and its distribution. Several genes responsible
for rare forms of monogenic obesity have been identiﬁed
in animal models, but only a few of these genes may
cause rare forms of monogenic obesity in humans (Barsh
et al. 2000). However, despite the fact that knowledge
of the genetics of obesity has increased substantially
over the past few years, genetic control of common
forms of human obesity is poorly understood. To date,
on the basis of candidate genes studies and genomewide
linkage studies, a number of genes and/or chromosomal
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regions have been reported to be linked or associated
with human obesity phenotypes, but causative genes
have not yet been identiﬁed (Chagnon et al. 2003).
BMI is a commonly used measure of obesity, and it
exhibits a complex relationship with T2D and other
measures of obesity (e.g., leptin). In view of these com-
plex relationships and interactions between measures of
obesity (BMI), leptin, and diabetes, it is hard to identify
the trait-speciﬁc genes inﬂuencing various obesity phe-
notypes because these phenotypes are under the inﬂu-
ence, not only of trait-speciﬁc genes, but shared genes
(pleiotropic genes) as well (Mahaney et al. 1995; Arya
et al. 2001b). One way to identify the trait-speciﬁc genes
is to adjust the given phenotype for the effects of other
correlated phenotypes and use the adjusted phenotype
in the genetic analysis. Thus, in this study we scanned
the genome and performed multipoint linkage analyses
to identify the susceptibility loci inﬂuencing variation
in common forms of obesity represented by the adjusted
BMI phenotype in Mexican Americans.
Subjects and Methods
San Antonio Family Diabetes Study
Data were obtained from low-income Mexican Amer-
ican families living in San Antonio, TX, whose members
were participants in the San Antonio Family Diabetes
Study (SAFDS). Probands for the SAFDS were subjects
with T2D identiﬁed in a prior epidemiological survey
(Stern et al. 1989, 1993). Family members included all
ﬁrst-, second-, and third-degree relatives of probands
aged 18 years. In this study, we used 430 individuals
from the 27 largest pedigrees for whom phenotypic and
genotypic data were available. An ∼10-cM map was
used for the multipoint linkage analyses. The Institu-
tional Review Board of the University of Texas Health
Science Center at San Antonio approved all procedures,
and all subjects gave written informed consent.
Phenotypes
BMI was calculated as weight (in kilograms) divided
by height squared (in meters). Leptin levels were mea-
sured by a commercial radioimmunoassay (Ma et al.
1996). T2D was diagnosed according to the WHO
plasma glucose criteria (World Health Organization
1999). Individuals who reported a history of diabetes
and stated that they were receiving insulin or oral an-
tidiabetic agents were also considered to have diabetes.
Since SAFDS families were ascertained on type 2 diabetic
probands, we corrected for ascertainment bias by con-
ditioning on likelihood of observing the BMI of the pro-
band with T2D in all analyses. In this study, we con-
ducted three types of analyses that differed by the
number of covariates included in a given model. The
ﬁrst analysis (BMI1) included age and sex terms as co-
variates. The second analysis (BMI2) included age and
sex terms, and T2D as covariates, and the third analysis
(BMI3) included age, sex terms, T2D, and leptin as
covariates.
Genotyping of Markers
A total of 439 individuals from the 27 largest SAFDS
pedigrees were initially selected for genotyping. DNA
was extracted fromwhite blood cells by use of proteinase
K digestion/phenol extraction and alcohol precipitation
in a semiautomated fashion on an ABI 341 RNA/DNA
extractor. Genotypic data were collected mainly by
PCR assays with radiolabeled oligonucleotide primers,
whereas data for some of the markers were collected
using ﬂuorescent dye-labeled primers purchased from
Research Genetics. These markers were PCR ampliﬁed
and loaded onto an Applied Biosystems Model 373 se-
quencer, and the data were analyzed with Applied Bio-
systems Genotyper software, as described elsewhere
(Duggirala et al. 1999). The details of our genotypic
data, including the procedures for checking Mendelian
discrepancies, were as described elsewhere (Duggirala et
al. 2000). In this study, we used a set of 326 highly
polymorphic microsatellite markers, which generated a
10-cM map.
Statistical Genetic Analysis
Multipoint Mapping Procedure
This method uses information on all availablemarkers
separated by known map distances and all possible bi-
ological relationships simultaneously in deciphering the
genetic architecture of a given quantitative phenotype.
Since the method requires the distances between the
markers to be known, the order of the loci spanning a
given chromosome and the likelihood sex-averaged map
distances between the loci were obtained employing Ko-
sambi’s mapping function using the program CRI-MAP
(Green et al. 1990). The advantage of the multipoint
approach is that it not only identiﬁes the location of a
susceptibility locus but also places CIs on the location
parameter, which makes it more powerful than two-
point analysis.
Variance Components Linkage Analysis
We used a pedigree-based multipoint variance-com-
ponents approach to test for linkage between marker
loci and the obesity phenotype, using a maximum-like-
lihood method (Amos 1994; Almasy and Blangero
1998). In this method, the expected genetic covariances
between relatives are speciﬁed as a function of the IBD
relationships at a marker locus, which is assumed to be
closely linked to a locus inﬂuencing the quantitative trait
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Table 1
Characteristics of SAFDS Subjects
Variable Value
Males 41.2%
Females 58.8%
T2D 26.3%
Age, mean  SD (years) 43.1  17.1
BMI, mean  SD (kg/m2) 30.0  6.7a
Leptin, mean  SD (ng/ml):
Males and Females 22.1  17.1
Males 11.1  7.9
Females 29.7  17.6
a Skewness p 0.9; kurtosis p 1.3.
in question. The covariance matrix for a pedigree can
be written as shown in the following equation:
n
2 2 2Qp P j  2Fj  Ij , i qi g e
ip1
where Q is the covariance matrix for a given pedigree;
P is a matrix with elements ( ) providing the expectedpijl
proportion of alleles at the speciﬁc chromosomal loca-
tion of the quantitative trait locus that individuals j and
l share IBD, which is estimated using genetic marker
data; is the additive genetic variance due to the major2jq
locus; F is the kinship matrix; is the variance due to2jg
residual additive genetic effects; I is an identity matrix;
and is the variance due to random environmental2je
effects. Multipoint IBD matrices were estimated using
Simwalk2 (Sobel et al. 2001) and were imported into
SOLAR (Almasy and Blangero 1998). All multipoint
variance-components linkage analyses were performed
according to the procedures outlined in SOLAR (Almasy
and Blangero 1998).
The null hypothesis that, for a given phenotype, the
additive genetic variance due to the QTL, , equals zero2jq
(no linkage) can be tested using the likelihood-ratio test.
The likelihood of a restricted model, in which is con-2jq
strained to 0, is compared with the likelihood of the
general model, in which genetic variance due to the QTL
( ) is estimated. The ln likelihood values of the general2jq
model and restricted model are then compared using the
likelihood-ratio test. Twice the difference between the ln
likelihood values of these models yields a test statistic
that is asymptotically distributed as a : mixture of a1 12 2
and a point mass at 0 (Self and Liang 1987). The2x1
likelihood value can be converted into a logarithm (base
10) of odds to obtain a LOD score that is equivalent to
the classical LOD score of linkage analysis. A LOD score
of 3.0 was considered to be strong evidence in support
of linkage, which is equivalent to a P value of .0001,
suggesting that evidence for linkage is 1,000 times
greater than the support for no linkage. Other chro-
mosomal regions across the genome with nominal P val-
ues of .01 or less (i.e., LOD scores 1.175) and LOD
scores of1.9 are considered to show potential linkages
and evidence suggestive of linkage, respectively.
Oligogenic Linkage Analysis
We also used a sequential strategy to identify multiple
loci affecting the variation in BMI. In this approach, the
genome was scanned for linkage and the chromosomal
location that yielded the largest marginal LOD scorewas
retained for further conditional analyses. Given the pu-
tative location of the ﬁrst locus, we scanned the genome
again and examined the resulting conditional LOD
scores. In the two-locus model, the position of the ﬁrst
locus is ﬁxed, and the location of the second locus is
allowed to vary through the whole genome. The QTL
variance ( ) for the ﬁrst locus is reestimated along with2hq
the second locus. Similarly, in the three-locus model, the
positions of the ﬁrst two loci are ﬁxed, but the effect
sizes are reestimated along with the third locus. LOD
scores from the oligogenic models can be either joint, if
they are compared to the polygenic null model, or con-
ditional, if they are compared to the linkage model con-
taining n1 loci (Blangero and Almasy 1997).
Robust LOD (LODR) Score Estimation
To verify our major ﬁnding on chromosome 4, we
performed simulation analysis. In the simulation anal-
ysis, a fully informative marker was simulated that was
not linked to the QTL inﬂuencing variation in BMI. For
this simulated marker, IBD information was calculated,
and then linkage analysis was conducted. By use of sim-
ulations, the empirical distribution of the LOD scores
under the assumption of multivariate normality was de-
termined, on the basis of information obtained from
100,000 replicates by the SOLAR program (Almasy and
Blangero 1998). The empirical distribution of the sim-
ulated LOD scores was used to assign percentiles to each
replicate, and an expected test statistic was calculated
on the basis of the percentile. The correction constant
was obtained by regressing the expected LOD scores on
the observed simulated LOD score, which is used to
adjust the observed original LOD scores to obtain robust
LOD (LODR) scores (Blangero et al. 2001).
Results
Descriptive statistics of the SAFDS subjects used in these
analyses are presented in table 1. The patterns of phe-
notypic, genetic, and environmental correlations (r) be-
tween trait pairs BMI, leptin, and T2D in Mexican
Americans are presented in table 2. The genetic corre-
lations between BMI and leptin and between BMI and
T2D were signiﬁcant ( ), whereas the geneticP ! .0001
correlation between leptin and T2D was not signiﬁcant
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Table 2
Phenotypic (rP ), Genetic (rG), and Environmental (rE )
Correlations between Phenotype Pairs
PHENOTYPE
PAIR
MEAN CORRELATION  SEa
rP rG rE
BMI and leptin .66  .03* .71  .09* .66  .06*
BMI and T2D .27  .07* .52  .23* .06  .16
Leptin and T2D .00  .08 .03  .34 .02  .15
NOTE.—Each trait is adjusted for age and sex terms.
a Signiﬁcant at .P ! .0001
Table 3
BMI Heritability (h2) in SAFDS
Individuals
Phenotypea N
h2
(%)
Variance
Explained
by Covariates
(%)
BMI1 430 49b 6
BMI2 430 48b 8
BMI3 386 49b 53
a BMI1 adjusted for age and sex terms;
BMI2 adjusted for age and sex terms and
for diabetes; BMI3 adjusted for age and sex
terms, diabetes, and leptin.
b Signiﬁcant at .P ! .0001
( ). Overall, polygenic heritability of BMI was es-P 1 .05
timated to be 48.6% 9.9%, which is highly signiﬁcant
( ), after the effects of age and sex are accountedP ! .0001
for (table 3). Given the large sizes of these pedigrees,
some related individuals may live in different house-
holds.We therefore estimated a household variance com-
ponent (i.e., household effect was estimated as a sur-
rogate measure of shared environmental inﬂuences),
which was not signiﬁcant ( ).Pp .24
Following the estimation of heritability, we per-
formed three multipoint univariate linkage analyses
across 22 autosomes for BMI. In the ﬁrst analysis
(BMI1), after accounting for the effects of age and sex
terms, we found evidence for linkage (LOD 2.1, Pp
) of a genetic region at 39 cM on chromosome 4.0019
near marker D4S2912. In the second analysis (BMI2),
after accounting for the covariate effects of age and sex
terms and T2D, we again found evidence for linkage
(LOD 2.8, ) at the same location. Finally, inPp .0003
the third analysis (BMI3), we removed the effects of
leptin in addition to those of age, sex, and T2D. We
again found a signiﬁcant linkage of BMI (LOD 4.5,
) to a nearby genetic location at 42 cM onPp .000003
chromosome 4p, near marker D4S2912. The robust
LOD score that corresponds to our maximum observed
LOD (4.5) is LODR p 4.1, , indicatingPp .000014
that type 1 error rates are consistent with asymptotic
expectation (i.e., the inﬂation of type 1 error rate is
minimal). Thus, the implicated marker region (at 2 cM
centromeric to marker D4S2912) appears to harbor a
major susceptibility locus for variation in BMI in Mex-
ican Americans. The LOD scores obtained for BMI from
the three analyses were plotted against map positions
on chromosome 4, as shown in ﬁgure 1. The other chro-
mosomal regions with multipoint LOD scores (11.175)
from only the BMI3 analysis are presented in table 4,
and the multipoint LOD proﬁles across the genome are
reported in ﬁgure 2.
Since multiple linkage peaks with some evidence for
linkage were observed in our genomewide search, we
extended variance-components linkage analysis to oli-
gogenic models to incorporate two or more loci simul-
taneously (Blangero and Almasy 1997; Blangero et al.
1999). As shown in table 5, genetic determinants of
BMI3 involve possibly three loci that are found on three
different chromosomes. In a joint two-locus analysis,
the two-locus model with a LOD score of 6.1 (corre-
sponding to a conditional LODR of 1.5 for the second
QTL, ) accounted for 35% and 23% of var-Pp .009
iance due to the QTLs on chromosomes 4 (D4S2912)
and 11 (D11S1984–D11S988), respectively. The three-
locus model with a total LOD score of 7.1 (correspond-
ing to a conditional LODR of 0.9 for the third QTL,
) accounted for 29%, 20%, and 16% of vari-Pp .03
ance due to the QTLs on chromosomes 4 (D4S2912),
11 (D11S1984–D11S988), and 7 (D7S506–D7S653),
respectively. These variance-component estimates for
the three-QTLmodel are likely to be more accurate than
those for the simpler models (Blangero and Almasy
1997; Blangero et al. 1999).
Discussion
The association between obesity and T2D has been rec-
ognized for decades, and several epidemiological studies
have indicated that obesity is a major risk factor for the
development of T2D (Kahn and Flier 2000; Nadler and
Attie 2001). Although it is clear that obesity inﬂuences
glucose metabolism through several physiological mech-
anisms, the cause and effect relationship between obesity
and diabetes is still not well understood (Kopelman
2000). Thus, it is often difﬁcult to identify which obese
individuals are more likely to become diabetics, since
∼80% of individuals with T2D are obese and only 10%
of obese individuals may become diabetics (Nadler et al.
2000). On the other hand, the relationship between ad-
iposity (i.e., BMI) and leptin levels has been found to be
signiﬁcant in both men and women of various popula-
tions (Maffei et al. 1995; Considine et al. 1996). How-
ever, the relationship between leptin and T2D is not
clear. Some studies have indicated a complex interrela-
tionship between leptin and insulin resistance (Tritos and
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Figure 1 Linkage of BMI to a genetic location on chromosome 4p in Mexican Americans
Mantzoros 1997; Donahue et al. 1999), whereas some
have failed to ﬁnd any association. For example, Haffner
et al. (1996) reported no association between leptin lev-
els and diabetic status even though leptin levels are sig-
niﬁcantly associated with BMI in Mexican Americans.
Although there is considerable residual variation in lep-
tin levels at a given BMI value, diabetic status does not
account for this variability. In this study, we therefore
used the BMI adjusted for the effects of leptin and T2D
to identify the genes that inﬂuence the common forms
of obesity, on the premise that power to localize a trait-
speciﬁc major gene may be increased by removing some
of the background noise due to the phenotypic associ-
ations between the correlated traits (Mahaney et al.
1995; Arya et al. 2001b).
We analyzed family data collected from Mexican
American subjects as part of the San Antonio Family
Diabetes Study to identify the trait-speciﬁc genes for a
single obesity phenotype (i.e., adjusted BMI) inMexican
Americans. As our study reveals, BMI adjusted for the
effects of leptin and T2D, which are strong correlates
of BMI, is highly and signiﬁcantly heritable. In addition,
our genome scan linkage analysis revealed that there are
loci with appreciable inﬂuences on BMI. More impor-
tantly, this genome scan provided strong evidence for
the presence of a novel locus inﬂuencing variation in
BMI on chromosome 4p. We observed the highest LOD
score of 4.5 for BMI3 near marker D4S2912 at 42 cM
from pter on chromosome 4p15.1, which provides
highly signiﬁcant support for linkage in a genomewide
scan. In fact, the linkage signal (LOD 4.5) was slightly
improved after saturation of the region with addition-
al markers between ﬂanking markers D4S2639 and
D4S1581, compared with our initial ﬁndings (LOD 4.3)
in the same region (Arya et al. 2001a).
This linkage ﬁnding has been replicated in a recent
study of severe obesity in women by Stone et al. (2002),
who found a highly signiﬁcant linkage to high BMI in
female patients at D4S2632 (4p15.1), with a multipoint
heterogeneity LOD of 6.1 and a nonparametric linkage
score of 5.3, located ∼5 cM telomeric to our region
(D4S2912, 4p15.1). Furthermore, this region on chro-
mosome 4p corresponds (∼5 cM apart) to the region
previously reported to be linked (D4S2397, 4p15.2,
LOD 2.3) to abdominal subcutaneous fat in the Quebec
family data (Perusse et al. 2001). The region on chro-
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Table 4
Chromosomal Regions (LOD 1.175, ) Linked to Obesity PhenotypeP  .01
(BMI3)
MARKER REGION CHROMOSOME
DISTANCE FROM PTER, IN
LOD
SCOREKosambi cM Haldane cM
D2S293–D2S383 2 115 135 2.9
D4S2912 4 36 42 4.5
D4S1548–D4S1090 4 175 195 1.3
D7S506–D7S653 7 90 102 1.9
D9S299–D9S930 9 113 124 2.1
D11S1984–D11S988 11 2 3 2.5
D11S4464 11 150 175 2.3
D18S858–D18S51 18 80 90 1.4
mosome 4p near marker D4S2912 (4p15.1) where we
found a signiﬁcant linkage signal contains two posi-
tional candidate genes: peroxisome proliferator acti-
vated receptor gamma coactivator 1 (PPARGC1 [pre-
viously called “PGC-1”], 4p15.1 [GenBank accession
number NT_006316; MIM 604517]) and cholecysto-
kinin A receptor (CCKAR, 4p15.1-p15.2 [NT_006316,
MIM 118444]) (de Weerth et al. 1993; Huppi et al.
1995).
The gene for PPARGC1 comprises 13 exons spanning
a genomic region of ∼98 kb and has a cytogenetic lo-
cation of 4p15.1 (LocusLink). PPARGC1 is a novel
transcriptional coactivator that coordinates the activi-
ties of many transcriptional factors that play an im-
portant role in adaptive thermogenesis (Lowell 1998;
Puigserver et al. 1998; Spiegelman et al. 2000), mito-
chondrial biogenesis (Wu et al. 1999a), mitochondrial
fatty acid oxidation (Vega et al. 2000), hepatic gluco-
neogenesis (Herzig et al. 2001; Yoon et al. 2001), and
glucose uptake (Michael et al. 2001). PPARGC1 coac-
tivates various nuclear receptors, including PPARg, and
promotes expression of mitochondrial proteins such as
UCP1, which plays a major role in thermogenesis, both
cold-induced and diet-induced, in brown adipose tissue
and skeletal muscle, which is a key component of energy
homeostasis and a metabolic defense against obesity
(Puigserver et al. 1998; Larrouy et al. 1999).
PPARGC1 increases total cellular respiration and mi-
tochondrial biogenesis through the coactivation of nu-
clear respiratory factor-1 (NRF-1) (Puigserver et al.
1998; Wu et al. 1999b). It promotes mitochondrial bi-
ogenesis through its ability to turn on the expression of
both NRF-1 and -2 and coactivates NRF-1 through pro-
tein-protein interactions (Wu et al. 1999a; Monsalve et
al. 2000). Both NRF-1 and NRF-2 bind to and regulate
the promoters of several genes encoding mitochondrial
proteins. Furthermore, it has been shown that expres-
sion of PPARGC-1 is decreased as a function of both
insulin resistance and obesity, which in turn leads to
decreased expression of NRF-dependent genes and thus
to metabolic disturbances such as insulin resistance and
diabetes (Patti et al. 2003). Thus, PPARGC1 plays a key
role in linking nuclear receptors to the transcriptional
program of adaptive thermogenesis, and increasing
PPARGC1 activity may be a potential mechanism for
energy dissipation and a therapeutic target for weight
loss (Puigserver et al. 1998). Recently, Esterbauer et al.
(2002) reported that, in middle-aged Austrian women,
two PPARGC1 polymorphisms have been associated
signiﬁcantly with BMI (0.006), with waist (0.01) and
hip (0.03) circumferences, and marginally with visceral
and subcutaneous fat, suggesting a role of PPARGC1
in obesity.
Another candidate gene near our peak signal on chro-
mosome 4p is the cholecystokinin A receptor (CCKAR),
a G protein-coupled 7-transmembrane spanning recep-
tor belonging to the rhodopsin family, which consists
of 5 exons covering 9,025 bp with a cytogenetic loca-
tion at 4p15.1-15.2 (de Weerth et al. 1993; Huppi et
al. 1995; Inoue et al. 1997; LocusLink). Both the
PPARGC1 and CCKAR genes are thus located centrally
on the same physical 22.5 Mb genomic sequence ref-
erence contig (NT_006316, accessed September 17,
2003) and are just 2.6 Mb apart, a distance containing
at least 26 known or suspected genes. This contig is
ﬂanked by markers D4S2912 and D4S1587, which en-
compass our linkage peak for adjusted BMI (BMI3).
CCKAR plays a role in mediating gallbladder con-
traction and secretion of pancreatic enzymes. This gene
has been implicated in food intake and satiety (Gutz-
willer et al. 2000; Beglinger et al. 2001), and CCKAR
gene promoter polymorphism is associated with body
fat (Funakoshi et al. 2000). Although evidence suggests
that preabsorptive factors, such as cholecystokinin, are
important cofactors in the regulation of energy intake,
little is known about the biochemical processes that con-
trol hunger and satiety. CCK has been shown to affect
the short-term control of food intake in animals and
humans, and is proposed to act as a hormonal satiety
signal (Drewe et al. 1992; Lieverse et al. 1994; Geary
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Figure 2 Chromosomal regions linked to BMI in a genome scan (LOD 1.175)
1996; Gutzwiller et al. 1999). For example, fat ingestion
stimulates the secretion of a number of gastrointestinal
hormones including CCK. In addition, CCK-like pep-
tides are endogenous signals that are mediated by CCKA
receptors, involved in the control of food intake in hu-
mans (Gutzwiller et al. 2000). Using a single-strand con-
formational polymorphism strategy, Inoue et al. (1997)
identiﬁed ﬁve sequence variants, including two missense
variants in patients with T2D and obesity, which may
be inﬂuencing obesity and diabetes. Moran and co-
workers (1998) showed that rats that do not express
CCKA receptors develop obesity, hyperglycemia, and
T2D.
Several other chromosomal regions across the ge-
nome that exhibited some evidence for linkage (LOD
11.175) to BMI correspond with previously reported
ﬁndings. The genomic region between markers D2S293
and D2S383 (2q12.2-2q14.3) on chromosome 2 (LOD
2.9) corresponds to a previously reported genomic re-
gion near markers D2S160 and D2S347 (2q13-2q14.3),
which may contain a QTL inﬂuencing obesity-related
phenotypes in a white population of European origin.
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Table 5
Results of the Oligogenic Analysis of Variation in Obesity Phenotype (BMI3)
MODEL AND QTL REGION CHROMOSOME
LOCATION
(cM)
SEQUENTIAL
LOD
% OF VARIATION
EXPLAINED BY LOCUS
First Second Third
One QTL:
D4S2912 4 42 4.5 47 … …
Two QTL:
D4S2912 4
D11S1984–D11S988 11 5 6.1 35 23 …
Three QTL:
D4S2912 4
D11S1984–D11S988 11
D7S506–D7S653 7 105 7.1 29 20 16
Other genomic regions on chromosomes 7q and 11q
correspond to ﬁndings from a number of studies. We
have identiﬁed a broader region (7q22.1-7q35) on chro-
mosome 7q that contains susceptibility gene(s) for obe-
sity or its related phenotypes—such as extremity skin-
folds, BMI, triglyceride, and high-density lipoprotein
cholesterol (HDL-C) levels—in Mexican Americans
(Duggirala et al. 1996, 2000; Arya et al. 2002). The same
region is also implicated by several other studies as in-
ﬂuencing BMI in other populations (Wu et al. 2002;
Platte et al. 2003). Also, the two genomic regions near
markers D11S1984 (11p15.5) and D11S4464 (11q24.1)
on chromosome 11 correspond to previously reported
genetic regions: a region near markers D11S1984–
D11S988 (11p15.5) linked to clinical gallbladder disease
(GBD) inMexican Americans (Duggirala et al. 2003) and
a second region, near markers D11S4464–D11S912
(11q24.1), linked to BMI in Pima Indians and other pop-
ulations (Hanson et al. 1998; Atwood et al. 2002; Ad-
eyemo et al. 2003).
Although ∼68 chromosomal regions have been iden-
tiﬁed as possibly harboring QTLs for human obesity-
related phenotypes (Chagnon et al. 2003), speciﬁc genes
inﬂuencing obesity are yet to be identiﬁed. Some of the
genomic regions hitherto identiﬁed to inﬂuence obesity-
related phenotypes involve chromosomes 2p (Comuzzie
et al. 1997; Hager et al. 1998), 6q (Duggirala et al.
2001; Atwood et al. 2002), 7q (Duggirala et al. 1996),
10p (Hager et al. 1998; Hinney et al. 2000), 11q, and
20q (Norman et al. 1998) and have been replicated
supporting the presence of genetic variants in these
regions that inﬂuence the risk of obesity. Thus, ge-
nomewide linkage analyses of such obesity-related phe-
notypes suggest that the observed variation in obesity
is attributable to more than one major gene.
Conclusions
Our genome scan results provide strong evidence for a
major gene inﬂuencing BMI, adjusted for T2D and lep-
tin, on chromosome 4p in Mexican Americans. This
linkage was conﬁrmed in an independent study of severe
obesity in Utah pedigrees and corresponds with linkage
ﬁndings from the Quebec Family Study. The implicated
genomic region on chromosome 4p contains two strong
positional candidate genes, PPARGC1 and CCKAR,
which have been shown elsewhere to have a major func-
tional role in the development of obesity. We have begun
positional cloning efforts to identify functional variants
in these positional candidate genes.
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